6/27/2025

Merck announces that the CDC's Advisory Committee on Immunization Practices has voted in favor of recommending Enflonsia for the prevention of respiratory infections caused by RSV in infants under 8...

Source: Finnhub

6/26/2025

Merck (MRK) closed the most recent trading day at $78.83, moving 1.05% from the previous trading session.

Source: Yahoo

6/26/2025

RAHWAY, N.J., June 26, 2025--ACIP Recommends Merck’s ENFLONSIA for Prevention of RSV in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season

Source: Yahoo

6/26/2025

Merck announced the U.S. Centers for Disease Control and Prevention Advisory Committee on Immunization Practices voted to recommend ENFLONSIA?? as an option for the prevention of respiratory...

Source: Finnhub

6/26/2025

Merck's growing pipeline, with nearly 20 new launches ahead, is set to reshape its portfolio as Keytruda's 2028 patent expiry nears.

Source: Yahoo

6/26/2025

The Europe proteomics market is expected to rise to $27.43 billion by 2034 from $8.77 billion in 2024, with a CAGR of 12.07%. Driving this growth are advancements in mass spectrometry and next-gen sequencing technologies enhancing protein analysis precision. The increased focus on personalized healthcare, catalyzed by biomarker discovery and disease profiling, amplifies demand. Support from EU funding, public-private partnerships, and strategic alliances further propels market expansion. Europe'

Source: Yahoo

6/26/2025

The external committee advising theU.S. Centers for Disease Control and Prevention on vaccinepolicy voted that all adults in the country receive a seasonalflu shot in single-dose forms that are...

Source: Finnhub

6/26/2025

U.S. Health Secretary Robert F. Kennedy Jr.'s newly revamped vaccine advisory panel voted on Thursday to recommend Americans receive seasonal influenza shots that are free from the mercury-based...

Source: Finnhub

6/26/2025

Alphabet can overcome legal headwinds and continue to perform well in the long term. Merck should be able to remain a leader in oncology despite mounting competition. Let's consider two stocks that meet these criteria: Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL), and Merck (NYSE: MRK).

Source: Yahoo

6/26/2025

U.S. Health Secretary Robert F.Kennedy Jr.'s newly revamped vaccine advisory panel voted onThursday to recommend Americans receive seasonal influenza shotsthat are free from the mercury-based...

Source: Finnhub

6/26/2025

U.S. Health Secretary Robert F.Kennedy Jr.'s newly revamped vaccine advisory panel voted onThursday to recommend use of Merck's recently approvedRSV antibody drug for infants 8 months or younger...

Source: Finnhub

6/26/2025

U.S. Health Secretary Robert F.Kennedy Jr.'s newly revamped vaccine advisory panel voted onThursday for recommending use of Merck's RSV antibodydrug for infants 8 months or younger whose mothers...

Source: Finnhub

6/26/2025

An advisory panel of the U.S.Centers for Disease Control and Prevention on Thursdayrecommended the use of Merck's respiratory syncytialvirus therapy, Enflonsia, for infants 8 months or younger,...

Source: Finnhub

6/25/2025

Zoetis Inc. (NYSE:ZTS) is one of the 10 Worst Aggressive Growth Stocks to Buy According to Short Sellers. On June 18, Stifel analyst Jonathan Block downgraded Zoetis Inc. (NYSE:ZTS)’s stock to “Hold” from “Buy,” reducing the price objective to $160 from $165. The firm warned that revenue growth might fall short of Wall Street expectations over the […]

Source: Yahoo

6/25/2025

The U.S. Centers for Disease Controland Prevention's revamped vaccine advisory panel on Wednesdaypostponed its vote on the use of respiratory syncytial virustherapies to Thursday. The...

Source: Finnhub

6/25/2025

BMY depends on Reblozyl, Opdualag and Breyanzi to offset revenue hits from generics and Medicare Part D impacts.

Source: Yahoo

6/25/2025

MRK breaks above its 50-day average but near-term headwinds and weak China sales challenge the bullish case.

Source: Yahoo

6/25/2025

June 25, 2025 1:12 pm ET New platform utilizes advanced data engineering and LLMs to enhance clinical study report development, helping deliver medicines to patients faster ...

Source: Finnhub

6/25/2025

Source: SeekingAlpha

6/25/2025

Merck & Co., Inc. (NYSE:MRK) is one of the 10 Best and Cheap Stocks to Buy Now. On June 18, Akash Tewari, an analyst from Jefferies, maintained the Buy rating on Merck & Co., Inc. (NYSE:MRK) with a price target of $138. The positive outlook is based on the stability of the company’s vaccine sales and […]

Source: Yahoo